These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20541671)

  • 1. The MENX syndrome and p27: relationships with multiple endocrine neoplasia.
    Molatore S; Pellegata NS
    Prog Brain Res; 2010; 182():295-320. PubMed ID: 20541671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.
    Pellegata NS; Quintanilla-Martinez L; Siggelkow H; Samson E; Bink K; Höfler H; Fend F; Graw J; Atkinson MJ
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15558-63. PubMed ID: 17030811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MENX.
    Pellegata NS
    Ann Endocrinol (Paris); 2012 Apr; 73(2):65-70. PubMed ID: 22542001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p27kip1: a new multiple endocrine neoplasia gene?
    Marinoni I; Pellegata NS
    Neuroendocrinology; 2011; 93(1):19-28. PubMed ID: 20980721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia syndromes associated with mutation of p27.
    Lee M; Pellegata NS
    J Endocrinol Invest; 2013 Oct; 36(9):781-7. PubMed ID: 23800691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MENX and MEN4.
    Pellegata NS
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):13-8. PubMed ID: 22584700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 4.
    Lee M; Pellegata NS
    Front Horm Res; 2013; 41():63-78. PubMed ID: 23652671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of multiple endocrine neoplasia.
    Wiedemann T; Pellegata NS
    Mol Cell Endocrinol; 2016 Feb; 421():49-59. PubMed ID: 26184857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple endocrine neoplasia, the old and the new: a mini review.
    Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
    G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEN4 and
    Alrezk R; Hannah-Shmouni F; Stratakis CA
    Endocr Relat Cancer; 2017 Oct; 24(10):T195-T208. PubMed ID: 28824003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
    Georgitsi M
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):425-37. PubMed ID: 20833334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a naturally-occurring p27 mutation predisposing to multiple endocrine tumors.
    Molatore S; Kiermaier E; Jung CB; Lee M; Pulz E; Höfler H; Atkinson MJ; Pellegata NS
    Mol Cancer; 2010 May; 9():116. PubMed ID: 20492666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
    Karhu A; Aaltonen LA
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R73-9. PubMed ID: 17613551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A
    Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27 variant and corticotropinoma susceptibility: a genetic and in vitro study.
    Sekiya T; Bronstein MD; Benfini K; Longuini VC; Jallad RS; Machado MC; Goncalves TD; Osaki LH; Higashi L; Viana J; Kater C; Lee M; Molatore S; Francisco G; Chammas R; Naslavsky MS; Schlesinger D; Gama P; Duarte YA; Lebrão ML; Zatz M; Meirelles O; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
    Endocr Relat Cancer; 2014 Jun; 21(3):395-404. PubMed ID: 24532476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of MENX-associated pituitary tumours.
    Marinoni I; Lee M; Mountford S; Perren A; Bravi I; Jennen L; Feuchtinger A; Drouin J; Roncaroli F; Pellegata NS
    Neuropathol Appl Neurobiol; 2013 Apr; 39(3):256-69. PubMed ID: 22524684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.
    Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S;
    Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
    Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
    Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.
    Seabrook A; Wijewardene A; De Sousa S; Wong T; Sheriff N; Gill AJ; Iyer R; Field M; Luxford C; Clifton-Bligh R; McCormack A; Tucker K
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2339-2349. PubMed ID: 35323929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.